Strados Labs
Philadelphia, US · Founded 2016 · Delaware limited partnership · 49 employees on LinkedIn · 8 known investors
Strados Labs builds wearable biosensors and a cloud platform that continuously capture and analyze respiratory data — including cough, spirometry, FeNO, and eCOA endpoints — in patients' daily lives. It combines AI detection with review by credentialed respiratory specialists to produce regulatory-grade, audit-ready evidence for pharma sponsors running decentralized clinical trials.
Founders & leadership
Strados Labs was founded in 2016 by Nicholas Delmonico, Nick Delmonico, and Yu Kan Au.
ND
Nicholas DelmonicoCo-founder
ND
Nick DelmonicoCEO & Co-founder
YK
Yu Kan AuClinician Co-founder
RP
Richard PowersNamed on SEC filing
SB
Steve BishopNamed on SEC filing
RB
Robert BallNamed on SEC filing
AL
Alex LevitNamed on SEC filing
Investors · 8
Band of AngelsSilicon Valley
BrincHong Kong · $100K – $500K
Broad Street AngelsPhiladelphia · $25K – $1M
Cathexis VenturesHouston · $250K – $1Mvia Mark Friday · inferred
Neer Venture Partners$25K – $500K
NextFab VenturesPhiladelphia
SOSVreportedNew York · $30K – $550K
Wavemaker Three-Sixty HealthreportedLos Angeles · $500K – $2M
Reported raises · per SEC filings
Form D private placements$5.8M disclosed across 4 rounds · 2019–2022
▶$585KraisedJun 2022 · 12 investors · OtherRule 506(b)
▶$585KraisedJun 2022 · 12 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Richard PowersExecutive Officer, Director
- Nicholas DelmonicoExecutive Officer, Director
- Steve BishopDirector
- Robert BallDirector
- Alex LevitDirector
- Offering amount
- $3M
- Amount sold
- $585K
- First sale
- May 2022
- Incorporated
- Limited Partnership, Delaware
- Federal exemptions
- 06b
▶$3.1MraisedNov 2021 · 29 investors · OtherRule 506(b)
▶$3.1MraisedNov 2021 · 29 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Richard PowersExecutive Officer, Director
- Steve BishopDirector
- Robert BallDirector
- Alex LevitDirector
- Nicholas DelmonicoExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $3.1M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$250KraisedMay 2020 · 1 investors · OtherRule 506(b)
▶$250KraisedMay 2020 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas DelmonicoExecutive Officer, Director
- Alex LevitDirector
- Richard PowersDirector
- Offering amount
- $750K
- Amount sold
- $250K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.9MraisedMay 2019 · 16 investors · OtherRule 506(b)
▶$1.9MraisedMay 2019 · 16 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas DelmonicoExecutive Officer, Director
- Richard PowersDirector
- Alex LevitDirector
- Offering amount
- $2.4M
- Amount sold
- $1.9M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapOsmosis367 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Eko Health362 shared keywordsEko develops FDA-cleared digital stethoscopes and AI-powered software that enables healthcare professionals to detect and diagnose cardiovascular disease with greater accuracy. The company serves clinicians and health systems seeking advanced diagnostic tools for cardiac care.
Power236 shared keywordsPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Companies competing with Strados Labs for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. ArmyArmy | Phase II | 2023 | $1.9M |
| U.S. ArmyArmy | Phase I | 2023 | $149.9K |
| National Science Foundation | Phase II | 2022 | $990.1K |
| National Science Foundation | Phase I | 2020 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Strados Labs do?
- Strados Labs builds wearable biosensors and a cloud platform that continuously capture and analyze respiratory data — including cough, spirometry, FeNO, and eCOA endpoints — in patients' daily lives. It combines AI detection with review by credentialed respiratory specialists to produce regulatory-grade, audit-ready evidence for pharma sponsors running decentralized clinical trials.
- Who founded Strados Labs?
- Strados Labs was founded by Nicholas Delmonico, Nick Delmonico, Yu Kan Au in 2016.
- Who are Strados Labs's investors?
- Strados Labs's investors include Band of Angels, Brinc, Broad Street Angels, Cathexis Ventures, Neer Venture Partners, NextFab Ventures, SOSV, Wavemaker Three-Sixty Health.
- How much funding has Strados Labs raised?
- Strados Labs has disclosed $5.8M raised across 4 rounds.
- Where is Strados Labs headquartered?
- Strados Labs is headquartered in Philadelphia, US.